These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28636525)

  • 21. 2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy.
    Cimino S; Maestrini V; Cantisani D; Petronilli V; Filomena D; Gatto MC; Birtolo LI; Piro A; Lavalle C; Agati L
    Echocardiography; 2019 Aug; 36(8):1475-1481. PubMed ID: 31260156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal left ventricular lead placement for cardiac resynchronization therapy in postmyocardial infarction patients.
    Muto C; Solimene F; Russo V; Nigro G; Rago A; Chianese R; Chiariello P; Ciardiello C; Caliendo L
    Future Cardiol; 2018 May; 14(3):215-224. PubMed ID: 29767542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Right ventricular global longitudinal strain provides prognostic value incremental to left ventricular ejection fraction in patients with heart failure.
    Motoki H; Borowski AG; Shrestha K; Hu B; Kusunose K; Troughton RW; Tang WH; Klein AL
    J Am Soc Echocardiogr; 2014 Jul; 27(7):726-32. PubMed ID: 24679740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy.
    Shamoun F; De Marco T; DeMets D; Mei C; Lindenfeld J; Saxon LA; Boehmer JP; Leigh J; Yong P; Feldman AM; Bristow MR
    JACC Heart Fail; 2019 Apr; 7(4):281-290. PubMed ID: 30738980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration.
    D'Onofrio A; Botto G; Mantica M; LA Rosa C; Occhetta E; Verlato R; Molon G; Ammendola E; Villani GQ; Bongiorni MG; Bianchi V; Gelmini GP; Valsecchi S; Ciardiello C
    J Cardiovasc Electrophysiol; 2014 May; 25(5):500-506. PubMed ID: 24494797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Right ventricular lead location and outcomes among patients with cardiac resynchronization therapy: A meta-analysis.
    Ali-Ahmed F; Dalgaard F; Allen Lapointe NM; Kosinski AS; Blumer V; Morin DP; Sanders GD; Al-Khatib SM
    Prog Cardiovasc Dis; 2021; 66():53-60. PubMed ID: 33864874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies.
    Ciconte G; Ćalović Ž; McSpadden LC; Ryu K; Mangual J; Caporaso I; Baldi M; Saviano M; Cuko A; Vitale R; Conti M; Giannelli L; Vicedomini G; Santinelli V; Pappone C
    J Interv Card Electrophysiol; 2019 Mar; 54(2):141-149. PubMed ID: 30483980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.
    Zanon F; Marcantoni L; Baracca E; Pastore G; Lanza D; Fraccaro C; Picariello C; Conte L; Aggio S; Roncon L; Pacetta D; Badie N; Noventa F; Prinzen FW
    Heart Rhythm; 2016 Aug; 13(8):1644-51. PubMed ID: 27450156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gauging the response to cardiac resynchronization therapy: The important interplay between predictor variables and definition of a favorable outcome.
    Petrovic M; Petrovic M; Milasinovic G; Vujisic Tesic B; Trifunovic D; Petrovic O; Nedeljkovic I; Petrovic I; Banovic M; Boricic-Kostic M; Petrovic J; Arena R; Popovic D
    Echocardiography; 2017 Mar; 34(3):371-375. PubMed ID: 28075037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
    St John Sutton M; Linde C; Gold MR; Abraham WT; Ghio S; Cerkvenik J; Daubert JC;
    JACC Heart Fail; 2017 Mar; 5(3):169-178. PubMed ID: 28254122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging.
    Eldadah ZA; Rosen B; Hay I; Edvardsen T; Jayam V; Dickfeld T; Meininger GR; Judge DP; Hare J; Lima JB; Calkins H; Berger RD
    Heart Rhythm; 2006 Apr; 3(4):435-42. PubMed ID: 16567291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.